empagliflozin/linagliptin

empagliflozin/linagliptin is a topic covered in the Davis's Drug Guide.

To view the entire topic, please or .

Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:

-- The first section of this topic is shown below --

General

Pronunciation:
em-pag-gli-floe-zin/lin-a-glip-tin

To hear audio pronunciation of this topic, purchase a subscription or log in.

Trade Name(s)

  • Glyxambi

Ther. Class.

antidiabetics

Pharm. Class.

sodium-glucose co-transporter 2 (SGLT2) inhibitors

dipeptidyl peptidase-4 (DDP-4) inhibitors

-- To view the remaining sections of this topic, please or --

General

Pronunciation:
em-pag-gli-floe-zin/lin-a-glip-tin

To hear audio pronunciation of this topic, purchase a subscription or log in.

Trade Name(s)

  • Glyxambi

Ther. Class.

antidiabetics

Pharm. Class.

sodium-glucose co-transporter 2 (SGLT2) inhibitors

dipeptidyl peptidase-4 (DDP-4) inhibitors

There's more to see -- the rest of this topic is available only to subscribers.